| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 60.15B | 59.66B | 61.44B | 68.90B | 87.33B | 78.60B |
| Gross Profit | 14.60B | 14.24B | 15.12B | 16.58B | 21.01B | 19.53B |
| EBITDA | 7.03B | 6.26B | 7.12B | 7.34B | 10.65B | 10.75B |
| Net Income | 1.74B | 1.62B | 1.30B | 225.00M | -627.00M | 5.52B |
Balance Sheet | ||||||
| Total Assets | 81.77B | 78.02B | 80.42B | 79.93B | 84.47B | 87.38B |
| Cash, Cash Equivalents and Short-Term Investments | 3.18B | 2.76B | 2.98B | 2.68B | 2.75B | 2.83B |
| Total Debt | 23.67B | 24.42B | 24.00B | 21.35B | 20.95B | 19.14B |
| Total Liabilities | 46.29B | 43.68B | 43.53B | 43.28B | 43.55B | 45.30B |
| Stockholders Equity | 34.28B | 33.19B | 35.60B | 35.28B | 36.60B | 40.79B |
Cash Flow | ||||||
| Free Cash Flow | 1.77B | 1.34B | 748.00M | 2.72B | 3.33B | 3.71B |
| Operating Cash Flow | 5.79B | 5.61B | 6.95B | 8.11B | 7.71B | 7.25B |
| Investing Cash Flow | -2.91B | -3.21B | -5.08B | -4.99B | -3.78B | -2.62B |
| Financing Cash Flow | -1.94B | -2.42B | -1.55B | -2.90B | -4.01B | -6.46B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
63 Neutral | €8.87B | 21.10 | 5.27% | 4.30% | -9.48% | -56.88% | |
62 Neutral | €46.97B | 12.41 | 5.24% | 5.16% | -11.46% | 137.39% | |
59 Neutral | €559.36M | 16.94 | -16.03% | ― | -19.00% | 32.12% | |
55 Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% | |
55 Neutral | €37.05B | 3.50 | -12.24% | 0.31% | -2.87% | 33.72% | |
51 Neutral | €175.69M | 10.50 | -9.06% | 2.27% | -11.18% | -434.70% | |
47 Neutral | €74.81M | 37.72 | 0.01% | ― | -12.44% | ― |